3 Myelofibrosis Clinical Trials in Los Angeles, CA (2026)

Q: How do I join a clinical trial in Los Angeles?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you.

Recruiting Myelofibrosis Studies in Los Angeles

NCT06479135Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

This clinical trial is evaluating whether addition of navtemadlin to ruxolitinib treatment will provide more clinical benefit than ruxolitinib alone for patients with Myelofibrosis who have a suboptim...

Los Angeles, CAPHASE3600 participantsKartos Therapeutics, Inc.

View Study Details

NCT04176198Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

This study is a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of nuvisertib (TP-3654) in patients with intermediate or...

Los Angeles, CAPHASE1240 participantsSumitomo Pharma America, Inc.

View Study Details

NCT05320198Recruiting

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

This phase 1b/2a open-label study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of DISC-0974 as well as categorize the effects on anemia response in subjects with myelofi...

Los Angeles, CAPHASE1150 participantsDisc Medicine, Inc

View Study Details

About Myelofibrosis Clinical Trials in Los Angeles

Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.

There are currently 3 myelofibrosis clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 990 participants. Research is being sponsored by Kartos Therapeutics, Inc., Sumitomo Pharma America, Inc., Disc Medicine, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myelofibrosis Clinical Trials in Los Angeles — FAQ

Are there myelofibrosis clinical trials in Los Angeles?

Yes, there are 3 myelofibrosis clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What myelofibrosis treatments are being tested?

The 3 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.

Data updated August 28, 2026 from ClinicalTrials.gov